Becton, Dickinson and Company (BD) has received the US Food and Drug Administration’s (FDA) 510(k) clearance for the Phasix ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced 510(k) clearance ...

BD (NYSE: BDX) announced today that it received FDA 510(k) clearance for its Phasix ST umbilical hernia patch.

Composed of Poly-4-hydroxybutyrate (P4HB), a biologically-derived material, with the added benefits of a proven hydrogel barrier based on Sepra® Technology, Phasix™ ST Umbilical Hernia Patch ...

This product is the market’s first fully absorbable hernia patch designed specifically for umbilical hernia repairs, marking a significant advancement in surgical options for patients.

SANTA BARBARA, CA, UNITED STATES, April 22, 2025 / EINPresswire.com / -- “Up to 12% of patients undergoing minimally invasive inguinal hernia repair may develop chronic postoperative inguinal pain, ...

This product is the market’s first fully absorbable hernia patch designed specifically for umbilical hernia repairs, marking a significant advancement in surgical options for patients. The Phasix™ ST ...

The MaxTack device, developed by Covidien (Medtronic, USA), features a push-button firing mechanism and absorbable, ...